Pakistan

DRAP Moves to Regulate Manufacturing and Sale of Alternative Medicines in Pakistan

ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has decided to bring the manufacturing and sale of alternative medicines under a formal regulatory framework.

DRAP has developed formal regulations and quality control parameters for alternative medicines and issued a memorandum outlining the new requirements.

The regulatory framework also covers vitamins, multivitamins and food supplements, making their registration and licensing mandatory.

According to the memorandum, manufacturers of alternative medicines have been given six months to obtain manufacturing licences, while an 18-month deadline has been set for the registration of these products.

Compliance with the new regulations has been made mandatory for the manufacturing and sale of all traditional medicines, including homeopathic products.

According to available figures, around 600 manufacturing units are producing alternative medicines in Pakistan, while approximately 1,000 importers are engaged in importing such products into the country.

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
WhatsApp
Get Alert